Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07084363 · ClinicalTrials.gov registry record · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
A NA study of Neuromuscular Block, Residual, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 1,032
- Enrollment target
- 1
- Study location
NCT07084363 is a NA study of Neuromuscular Block, Residual that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,032 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07084363, a NA study of Neuromuscular Block, Residual, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,032 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effect of quantitative block monitoring versus less expensive qualitative monitoring treatment effects on the lowest SpO2/FiO2 ratio in the PACU. The results will be incorporated into an enhanced recovery pathway for surgical patients.
Conditions Studied
Interventions
- DEVICE Quantitative monitoring
- OTHER Qualitative monitoring
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,032 participants |
| Start Date | 2025-09-22 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07084363
The ClinicalTrials.gov registry entry for NCT07084363 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,032 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuromuscular Block, Residual appearing as the primary indexed condition, and to 2 interventions - of which Quantitative monitoring is the first listed.
NCT07084363 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07084363 about?
NCT07084363 is a clinical study titled "Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery". The purpose of this study is to assess the effect of quantitative block monitoring versus less expensive qualitative monitoring treatment effects on the lowest SpO2/FiO2 ratio in the PACU. The results will be incorporated into an enhanced recovery pathway for surgical patients.
What is the current status of trial NCT07084363?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,032 participants. The study started on 2025-09-22. Estimated completion is 2026-04-01.
What conditions does trial NCT07084363 study?
This clinical trial studies the following conditions: Neuromuscular Block, Residual.
What interventions are being tested in trial NCT07084363?
The interventions under investigation include: Quantitative monitoring (DEVICE), Qualitative monitoring (OTHER).
Who is sponsoring clinical trial NCT07084363?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07084363 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.